Pushing the frontiers in retinal imagining, Optos’s most advanced ultra-widefield (UWF) scanning laser ophthalmoscope and spectral domain optical coherence tomography (OCT) solution, MonacoPro, has launched.
Danish ophthalmic laser technology company Norlase’s latest innovation, Lynx, a pattern laser indirect ophthalmoscope (LIO), has received the US Food and Drug Administration (FDA) premarket notification 510(k) clearance and the CE mark.
New research by US company Cognition Therapeutics suggests its experimental oral drug zervimesine (CT1812) may help address key cellular dysfunctions in dry age-related macular degeneration (AMD), rep
European researchers found the incidence of retinal detachment (RD) after refractive lens exchange (RLE) was approximately double that observed after cataract surgery with at least 24 months follow-up
The 14th and 15th Down Under Microsurgical Skills courses were completed in the Sight for Life Foundation Laboratory at Sydney Hospital in January. More than 30 Australian and seven Kiwi first-year vo
The prevalence and severity of refractive and corneal astigmatisms increased among children after the Covid-19 pandemic, a population-based cross-sectional study from Hong Kong found. In a coh
Patients with dry eye disease (DED) reported symptom relief in as early as five and 60 minutes after a single administration of Bausch + Lomb’s new ophthalmic solution Miebo, with relief maintained th
A 31-year-old Irishman can read again after becoming the country’s first patient to receive Luxturna to treat RPE65-inherited retinal dystrophy.
A recent study of more than 280,000 people in Wales found the live-attenuated varicella zoster virus vaccine (Zostavax) reduced their risk of a new dementia diagnosis by 20% over a seven-year period.
A team of New Zealand researchers has shown that age appears to be a key factor influencing the underlying aetiology and clinical course of uveitis. Published in the American Journal of Ophthalmolog
Sandwiched between the brutalist concrete blocks of the Western Australia Commonwealth Court and the Perth Concert Hall, the Duxton Hotel was the setting for the 2025 Australian and New Zealand Glauco
A literature review comparing repeated low-level red light (RLRL) therapy with single vision spectacles (SVS) found RLRL treatment led to “considerable reductions” in both axial length (AL) and spheri